Syed Ali Arsal

Syed Ali Arsal

Auto-generated profile, based on publicly available information

Syed Ali Arsal

Shaheed Mohtarma Benazir Bhutto Medical College Karachi Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2023 in Egyptian Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
Umer IqbalUmer Iqbal
Umer Iqbal
AKAashish Kumar
Aashish Kumar
SASyed Ali Arsal
Syed Ali Arsal
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
SAShafin Bin Amin
Shafin Bin Amin
SWSameeka Waqas
Sameeka Waqas
Background: Traumatic brain injury has a crippling impact on sufferers’ quality of life, and numerous therapy techniques are being researched to address this problem. In this study, we compared the superiority of HS against mannitol as one such element of treating TBI patients. Objective: To compare the efficacy of hypertonic saline and mannitol and demonstrate superiority of one group over the other. Method: Our meta-analysis included only randomized controlled trials that compared the efficacy of mannitol and hypertonic saline in the treatment of traumatic brain injury. The literature search was done using a variety of databases, like Google Scholar, PubMed, and the Cochrane Library. From each of the included RCTs, accurate data extraction, bias risk assessment, and statistical analysis were carried out. Result: There are 748 patients among the 15 RCTs. Our primary outcomes are mortality and functional outcomes, and our secondary outcomes include treatment failure, osmolality, intracerebral pressure (ICP), cerebral perfusion pressure (CPP), serum sodium (Na), partial pressure of oxygen in brain tissue (PBTO2), duration of elevated ICP, mean arterial pressure, hematocrit level, and central venous pressure. The comparison showed non-significant results for mortality (RR = 0.73, 95% CI 0.49–1.08; p = 0.12) and functional outcome (RR = 1.15, 95% CI = 0.74–1.80; p = 0.53). HS is linked to higher Na levels (RR = 4.55, 95% CI 1.34–7.76, P = 0.005, I2 = 96%). Despite performing a sensitivity analysis due to the heterogeneities in our various outcomes, the findings were still unreliable. Conclusion: Our study revealed inconsequential trends for HS and mannitol, and no conclusion was made. We believe the two medications to be equally effective, but there is still opportunity for improvement as more studies are carried out. Eventually, a conclusive decision can be reached in the future.

7 May 2024 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
HRHussain Sohail Rangwala
Hussain Sohail Rangwala
HFHareer Fatima
Hareer Fatima
MAMirha Ali
Mirha Ali
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
BRBurhanuddin Sohail Rangwala
Burhanuddin Sohail Rangwala
MMMuhammad Saqlain Mustafa
Muhammad Saqlain Mustafa

3 November 2023 in Journal of Medicine, Surgery, and Public Health
Verified
Journal Article
Open access
SASyed Ali Arsal
Syed Ali Arsal
AKAashish Kumar
Aashish Kumar
MSMehwish Soomro
Mehwish Soomro
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
Introduction: Dercum's disease, or adiposis dolorosa, is a rare medical disorder characterized by chronic, debilitating pain in adipose tissue accompanied by subcutaneous lumps. This case report highlights the diverse clinical manifestations, diagnostic challenges, and management strategies of Dercum's disease. Case presentation: We present a 40-year-old male with a 12-year history of subcutaneous growths, initially painless. Over the past year, two enlarging nodules on the back and forearm led to discomfort and occasionally elevated body temperature. Physical examination revealed tender nodules with no skin changes. Ultrasound confirmed subcutaneous lipomas. A diagnosis of Dercum's disease was established, guiding the management approach with pain relief and modalities like liposuction and lipectomy for problematic nodules. Discussion: Dercum's disease's epidemiology remains unclear, listed as a disease of unknown prevalence. Imaging modalities, particularly ultrasound, play a crucial role in diagnosis, offering cost-effectiveness and safety. Differential diagnoses include lipedema, multiple symmetric lipomatosis, and familial multiple lipomatosis, necessitating careful clinical assessment. No correlation with malignancy has been reported. The complexity of Dercum's disease underscores the importance of thorough evaluations to differentiate it from related adipose tissue disorders. Conclusion: In conclusion, Dercum's disease presents a challenge due to its rarity, diagnostic complexity, and varied clinical manifestations. Beyond chronic pain, its association with obesity, joint issues, and metabolic changes emphasizes the need for comprehensive management. Despite ongoing research, the exact etiology remains elusive, warranting continued efforts for awareness, understanding, and improved therapeutic strategies. As medical awareness grows, collaborative research can enhance the knowledge and care of individuals afflicted by Dercum's disease.

22 December 2025 in Health Science Reports
Verified
Journal Article
Open access
AKAyesha Khan
Ayesha Khan
SESyeda Emmama
Syeda Emmama
MAMahnoor Aamir
Mahnoor Aamir
MMMunazzah Marium
Munazzah Marium
IRIftikhar Rashid
Iftikhar Rashid
Inibehe Ime OkonInibehe Ime Okon
Inibehe Ime Okon
Introduction: Thyroidectomy is a routine operation for diverse thyroid diseases between benign and malignant. In such cases, the complications and postoperative pains, such as nausea, vomiting, and hemodynamic instability, complicate recovery and lengthen hospital stays. Lidocaine may prove beneficial due to its analgesic, anti‐inflammatory, and antihyperalgesic actions. The current systematic review and meta‐analysis assessed the effect of IV lidocaine infusion on postoperative pain and its complications in patients undergoing total thyroidectomy. Methods: A systematic review of published RCTs between 2016 and 2023 was conducted using PubMed, Embase, and Google Scholar. Their inclusion criteria were the comparison of IV lidocaine versus placebo in managing patients undergoing thyroidectomy. The primary outcomes included postoperative pain by VAS measurements. Secondary outcomes included MAP, heart rate at extubation, and PONV. A random effects model was applied for the analysis, whereas statistical evaluation was done using RevMan 5.2. Results: A total of five RCTs of 375 patients were summarized, where 172 patients were in the lidocaine group and 203 in the placebo group. Significant reduction in postoperative pain of IV lidocaine was shown (SMD = −1.24; 95% CI: −2.7 to 0.30; I ² = 97%, p = 0.11), heterogeneity was also reduced in a sensitivity analysis with I ² = 46%. Extubation MAP and heart rate were also significantly lower (SMD for MAP = −1.27, p = 0.47; SMD for heart rate = −1.36, p = 0.11). PONV did not show any difference, whereas cough scores were remarkably improved (RR = 0.42, 95% CI = 0.28 to 0.63). Conclusion: IV lidocaine shows potential in reducing postoperative pain, improving hemodynamic stability, and decreasing cough incidence in thyroidectomy patients. However, its effect on PONV remains unclear, warranting further investigation.

13 March 2026 in Health Science Reports
Verified
Journal Article
Open access
MUMarha Zaheer Uddin
Marha Zaheer Uddin
HHHira Hameed
Hira Hameed
AIAnoosha Muhammad Iqbal
Anoosha Muhammad Iqbal
MIMuhamad Irfan
Muhamad Irfan
SMSanhia Maheshwari
Sanhia Maheshwari
Inibehe Ime OkonInibehe Ime Okon
Inibehe Ime Okon
Introduction: Osteoporosis is a bone disorder highly prevalent in post‐menopausal women and is an important predisposing factor towards bone fractures. It is commonly classified based on BMD, which is estimated via DEXA scan. It is an important issue worldwide and requires a multidisciplinary approach to be controlled. Methods: Utilizing online sources including PubMed, Embase, Cochrane, and Google Scholar, a thorough literature search was conducted. To determine the best treatment options with fewer difficulties and adverse events and more good results. There were discovered to be 15 RCTS that qualified. The study was carried out per PRISMA recommendations. Results: According to the outcomes generated from the study, there was a significantly reduced rate of overall vertebral and non‐vertebral fractures with teriparatide use along with data supporting increased BMD observed in the teriparatide group. Importantly, there was a reduction in death rate too observed in the intervention group. The results were also consistent with our various secondary outcomes. Conclusion: We can conclude from the outcomes that a clinically significant result was generated in the group using teriparatide in various aspects. There were still some confounding factors present that need to be addressed to increase the yield of the study, and with increasing research in the field, more comprehensive studies are required in the future to reach a definitive outcome.